Latest News for: qilu

Edit

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide

Nasdaq Globe Newswire 27 Jan 2026
Lisata regains full development rights to certepetide in the Greater China Region. Lisata regains full development rights to certepetide in the Greater China Region ... .
  • 1
×